AIDAP3

Across TCGA pan-cancer cohorts, AIDAP3 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated AIDAP3 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher AIDAP3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated AIDAP3 expression acts as an unfavorable survival marker, although some lineages such as LAML and HNSC show a favorable association.

STAD, PAAD, and KICH are the cancer types where AIDAP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.140	0.535	.001	105	view →
PAAD	OS	Tertile	All	0.137	0.616	<.001	90	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	54	view →
LUAD	OS	Tertile	II,III,IV	0.452	0.757	.009	54	view →
LAML	DFS	Tertile	All	0.659	0.372	<.001	54	view →
KIRC	OS	Tertile	All	0.488	0.669	.005	42	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
CESC	OS	Tertile	III,IV	0.167	0.657	.044	18	view →
HNSC	OS	Tertile	All	0.939	0.744	.042	3	view →
LIHC	OS	Tertile	All	0.515	0.786	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

AIDAP3–STAD (OS)

Open the STAD breakdown →